Open Access Statement

1. Open Access

Starting from June 21, 2022, China Pharmacy officially transitioned to an open access journal. All articles published from June 21, 2022 onwards will be immediately and permanently available for free on the journal’s official website (https://journal.china-pharmacy.com/), with authors and readers permitted to copy and distribute the articles under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Deed (CC-BY-NC-ND 4.0). Articles published before June 21, 2022 can be accessed via platforms such as CNKI, Wanfang, and VIP databases.

2. License Policy

China Pharmacy uses the CC-BY-NC-ND 4.0 license to share its articles:https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en

Authors agree to have their articles published under the CC-BY-NC-ND 4.0 license. All users of the journal's articles must comply with the CC-BY-NC-ND 4.0 terms. This license allows users to copy and distribute the work in any medium and format under the following terms:

1.      Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

2.      NonCommercial — You may not use the material for commercial purposes .

3.      NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.

4.      No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

3. Archiving Policy

Article Archiving

From June 21, 2022, all articles published in China Pharmacy are open access and published under the CC BY-NC-ND 4.0 license. These articles will be immediately and permanently archived on the journal's website, available for free to all users, with search and download capabilities. All articles published before the journal’s transition to open access have been digitally archived, and readers can access them via platforms such as CNKI, Wanfang, and VIP databases.

All articles published from June 21, 2022, onwards will be managed under the CC BY-NC-ND 4.0 license. When using or reusing these materials, please adhere to the terms of the license and appropriately cite the source and author information. Articles published before June 21, 2022, that are freely available for access will remain under full copyright, and no one may use or reuse the archived content without explicit permission from the copyright holder.

Author Self-Archiving

China Pharmacy allows authors to store all versions of their articles in institutional or other repositories of their choice. The article metadata in these repositories must accurately indicate the journal’s publication details and should be cited as the preferred citation format.

Editorial Office of China Pharmacy